Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%

Healthcare

Page 79
  1. Jan 05, 2026 · 16:21 · HELP

    Cybin starts trading on Nasdaq

    Cybin starts trading on Nasdaq

    01
  2. Jan 05, 2026 · 08:01 · PHRX

    PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

    PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

    02
  3. Jan 02, 2026 · 17:26 · VIVI

    Tempramed reviews 2025, outlines 2026 plans

    Tempramed reviews 2025, outlines 2026 plans

    03
  4. Jan 02, 2026 · 16:20 · OTC

    Ocumetics closes $788,380 first tranche of placement

    Ocumetics closes $788,380 first tranche of placement

    04
  5. Jan 02, 2026 · 09:01 · OTC

    Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital

    Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital

    05
  6. Jan 02, 2026 · 08:01 · PHRM

    PharmaTher CEO Publishes Letter to Shareholders

    PharmaTher CEO Publishes Letter to Shareholders

    06
  7. Dec 31, 2025 · 20:45 · XRTX

    XORTX makes board changes

    XORTX makes board changes

    07
  8. Dec 31, 2025 · 20:04 · VIVI

    Tempramed expands distribution partnership in S. Korea

    Tempramed expands distribution partnership in S. Korea

    08
  9. Dec 31, 2025 · 18:15 · XRTX

    XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

    XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

    09
  10. Dec 31, 2025 · 18:13 · HEM

    Hemostemix closes $480,000 financing

    Hemostemix closes $480,000 financing

    10
  11. Dec 31, 2025 · 17:02 · VIVI

    TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

    TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

    11
  12. Dec 31, 2025 · 16:01 · AGN

    Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

    Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

    12
  13. Dec 31, 2025 · 15:13 · NURS

    Hydreight to distribute HSC's at-home STI testing kits

    Hydreight to distribute HSC's at-home STI testing kits

    13
  14. Dec 31, 2025 · 14:39 · HEM

    Hemostemix Closes $480,000 Private Placement at $0.12 per Share

    Hemostemix Closes $480,000 Private Placement at $0.12 per Share

    14
← Newer Older →